Discover 700 paid clinical trials in Oklahoma. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oklahoma offers many options for individuals interested in paid research studies as both healthy participants and those with specific health conditions. Leading research centers in Oklahoma City, Tulsa, and Norman are recruiting volunteers, giving access to the latest treatments and specialized care.
Filter
1
Filter results
Results: 700
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke
for
Stroke, Weakness of Extremities as Sequela of Stroke
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 18 - 70+
Code: NCT03980457
Recruiting
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
for
Relapsing Multiple Sclerosis
Location: Boston MA, Foxborough MA, Wellesley MA,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT05877963
Phase3, Recruiting
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
for
Small Cell Lung Cancer (SCLC),
Location: Boston MA, New Haven CT, Baltimore MD, Fairfax VA,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05652686
Phase1, Phase2, Recruiting
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Boston MA, The Bronx NY, New York NY, Burlington VT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05614739
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
for
Paroxysmal Atrial Fibrillation
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 21 - 70+
Code: NCT05172765
Recruiting
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Norfolk VA, Miami FL, Charleston SC, Niagara Falls,
Sponsor: LEO Pharma
Sex: All
Age: 0 - 11
Code: NCT06311682
Phase3, Recruiting
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
for
Metastatic Colorectal Carcinoma,
Location: The Bronx NY, Pittsburgh PA, Gainesville FL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05803382
Phase1, Recruiting
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
for
Irritability Associated With Autism Spectrum Disorder
Location: New Haven CT, The Bronx NY, New York NY, Orangeburg NY,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 5 - 17
Code: NCT06706674
Phase3, Recruiting
Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer
for
Head and Neck Cancer, Gynecologic Cancer, Cervical Cancer,
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 18+
Code: NCT05850663
Recruiting
REVEAL Biomarkers of Engraftment After Alternative Donor HSCT
for
Primary Graft Failure
Location: Atlanta GA, Ann Arbor MI, Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 4 - 70+
Code: NCT03541889
Phase1, Recruiting
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
for
Proteinuric Kidney Disease
Location: Bloomfield CT, Laurelton NY, Maspeth NY, Jersey City NJ,
Sponsor: Maze Therapeutics
Sex: All
Age: 18 - 68
Code: NCT06830629
Phase2, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
for
Asthma
Location: Boston MA, Hawthorne NY, Staten Island NY,
Sponsor: AstraZeneca
Sex: All
Age: 5 - 11
Code: NCT06023589
Phase3, Recruiting
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
for
Advanced Malignant Solid Neoplasm,
Location: New Haven CT, Trumbull CT, Bethesda MD, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05691491
Phase1, Phase2, Recruiting
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: New York NY, New Brunswick NJ, Orlando FL,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT05932862
Phase1, Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors